Korro Bio, Inc.(KRRO)

Biotechnology · Cambridge, MA

$9.76-0.21 (-2.11%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T21:32:42.237Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:32:42.237Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 9.76
Unrounded diluted TTM EPS · period ending 2026-06-30: -10.01

FMP input reference: eea6c7d5cd6e3fe508f4e89a8ac0afa25f3437e05bd10ab9ad2dfceb562d4ef8

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

KRRO PE Ratio Metrics

PE RATIO

N/A

KRRO Competitors' PE Ratio

KRRO

Korro Bio, Inc.

Current

Market Cap

$97.14M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs KRRO

Market Cap

$97.90M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNXU

Conexeu Sciences Inc.

vs KRRO

Market Cap

$97.94M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIST

Milestone Pharmaceuticals Inc.

vs KRRO

Market Cap

$95.14M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OKUR

OnKure Therapeutics, Inc.

vs KRRO

Market Cap

$99.62M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PARK

Park Dental Partners, Inc. Common Stock

vs KRRO

Market Cap

$93.96M

PE Ratio

N/A

TTM Avg

13.33

3Y Avg

13.33

5Y Avg

13.33

JYNT

The Joint Corp.

vs KRRO

Market Cap

$101.36M

PE Ratio

26.82

TTM Avg

39.41

3Y Avg

48.57

5Y Avg

115.64

ANIX

Anixa Biosciences, Inc.

vs KRRO

Market Cap

$102.75M

PE Ratio

N/A

TTM Avg

597.78

3Y Avg

597.78

5Y Avg

597.78

BDTX

Black Diamond Therapeutics, Inc.

vs KRRO

Market Cap

$103.14M

PE Ratio

N/A

TTM Avg

17.69

3Y Avg

17.69

5Y Avg

17.69

RLYB

Rallybio Corporation

vs KRRO

Market Cap

$90.64M

PE Ratio

2.19

TTM Avg

2.16

3Y Avg

2.16

5Y Avg

2.16

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Korro Bio, Inc. (KRRO)	$97.14M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$97.90M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$97.94M	N/A	N/A	N/A	N/A
Milestone Pharmaceuticals Inc. (MIST)vs ›	$95.14M	N/A	N/A	N/A	N/A
OnKure Therapeutics, Inc. (OKUR)vs ›	$99.62M	N/A	N/A	N/A	N/A
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$93.96M	N/A	13.33	13.33	13.33
The Joint Corp. (JYNT)vs ›	$101.36M	26.82	39.41	48.57	115.64
Anixa Biosciences, Inc. (ANIX)vs ›	$102.75M	N/A	597.78	597.78	597.78
Black Diamond Therapeutics, Inc. (BDTX)vs ›	$103.14M	N/A	17.69	17.69	17.69
Rallybio Corporation (RLYB)vs ›	$90.64M	2.19	2.16	2.16	2.16

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$9.76

Forward EPS (Est.)

$-5.31

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

KRRO PE Ratio Metrics

KRRO Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics